daclatasvir

Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C Regimen
Yahoo
Wed, 05/20/15 - 10:20 am
Bristol-Myers Squibb
FDA
breakthrough therapies
daclatasvir
hepatitis C
sofosbuvir
Bristol-Myers says hepatitis C drug combination succeeds in study
Yahoo/Reuters
Sun, 04/26/15 - 09:18 am
Bristol-Myers Squibb
hepatitis C
daclatasvir
FDA to review re-submitted Bristol-Myers hepatitis C drug
Yahoo/Reuters
Thu, 03/12/15 - 09:44 pm
FDA
Bristol-Myers Squibb
daclatasvir
hepatitis C
Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study
Yahoo/Reuters
Thu, 02/26/15 - 04:46 pm
Bristol-Myers Squibb
hepatitis C
HIV
daclatasvir
FDA declines to approve Bristol-Myers hepatitis drug
Yahoo/Reuters
Wed, 11/26/14 - 12:08 pm
hepatitis C
Bristol-Myers Squibb
FDA
daclatasvir
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir
Yahoo/Zacks.com
Wed, 11/12/14 - 08:33 am
Bristol-Myers Squibb
hepatitis C
daclatasvir
ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients
Yahoo/BusinessWire
Sat, 11/8/14 - 11:35 am
daclatasvir
sofosbuvir
hepatitis C
hepatitis
Bristol-Myers Squibb
Bristol-Myers Plan to Widen Access to its Hep C Drug is Criticized
WSJ Pharmalot
Mon, 11/3/14 - 03:40 pm
Bristol-Myers Squibb
hepatitis C
Daklinza
daclatasvir
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?
Motley Fool
Tue, 04/15/14 - 10:36 am
hepatitis C
Gilead Sciences
Sovaldi
Merck
Bristol-Myers Squibb
daclatasvir
asunaprevir
MK-5172
MK-8742
Encouraging Data from Bristol-Myers
Yahoo/Zacks
Sat, 04/12/14 - 10:20 am
Bristol-Myers Squibb
HCV
hepatitis
hepatitis C
daclatasvir
asunaprevir
Bristol-Myers hepatitis C treatment cures up to 90 pct -study
Yahoo/Zacks.com
Thu, 04/10/14 - 07:35 am
Bristol-Myers Squibb
hepatitis C
daclatasvir
asunaprevir
Bristol-Myers submits NDAs for Hep C drugs
Seeking Alpha
Mon, 04/7/14 - 09:57 am
Bristol-Myers Squibb
daclatasvir
asunaprevir
hepatitis C
FDA
Big Pharma Ramps Up Hep C Strategies
Yahoo/Investors Business Daily
Wed, 03/19/14 - 07:22 pm
hepatitis C
Sovaldi
Gilead Sciences
daclatasvir
Bristol-Myers Squibb
AbbVie
Enanta Pharmaceuticals
Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C
Yahoo
Mon, 02/24/14 - 09:55 am
daclatasvir
breakthrough therapies
FDA
Bristol-Myers Squibb
hepatitis C
Gilead Vs. Challengers In The Hepatitis C Race
Seeking Alpha
Thu, 11/7/13 - 09:52 am
Gilead
hepatitis C
AbbVie
Bristol-Myers Squibb
JNJ
Merck
simeprevir
sofosbuvir
daclatasvir
Bristol seeks Japan approval of all-oral hepatitis C treatment
Yahoo/Reuters
Sat, 11/2/13 - 11:56 am
Bristol-Myers Squibb
daclatasvir
asunaprevir
hepatitis C
hepatitis
3 Companies Racing to Transform Hepatitis-C Treatment
Motley Fool
Thu, 09/19/13 - 02:58 am
hepatitis C
Gilead
sofosbuvir
AbbVie
Bristol-Myers Squibb
daclatasvir
asunaprevir
BMS-791325
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Fri, 07/19/13 - 11:38 am
hepatitis C
AbbVie
Bristol-Myers Squibb
Gilead
Idenix
sofosbuvir
ledipasvir
daclatasvir
asunaprevir
BMS-791325
IDX20963
Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study
Bloomberg
Sun, 04/28/13 - 12:04 pm
Gilead Sciences
Bristol-Myers Squibb
hepatitis C
hepatitis
sofosbuvir
daclatasvir
Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race
TheStreet.com
Tue, 04/23/13 - 11:21 am
Gilead
Bristol-Myers Squibb
hepatitis C
sofosbuvir
daclatasvir
asunaprevir
BMS-791325

Pages